Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8 <sup>+</sup> T cell traffickingDavid J. Taggart, Mihaela Lorger, Karen J. Scott et al.|Proceedings of the National Academy of Sciences|2018Cited by 209